You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) AMINOBENZOIC ACID


✉ Email this page to a colleague

« Back to Dashboard


Market Dynamics and Financial Trajectory for Aminobenzoic Acid (P-Aminobenzoic Acid, PABA)

Last updated: March 12, 2026

What is Aminobenzoic Acid and Its Role?

Aminobenzoic acid (ABA), also known as p-aminobenzoic acid (PABA), is an organic compound used primarily as a UV filter in sunscreens and skincare products. It also functions as an intermediate in manufacturing antibiotics, dyes, and other chemicals. The global demand stems from its application in cosmetic, pharmaceutical, and industrial sectors.

Market Size and Forecast

The global aminobenzoic acid market was valued at USD 150 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4.8% during 2023-2028, attributable to expanding cosmetic applications and regulatory approvals for usage in pharmaceuticals.

Year Market Value (USD million) Growth Rate (%)
2022 150 -
2023 157.2 4.8
2024 164.9 4.8
2025 172.9 4.8
2026 181.4 4.8
2027 190.4 4.8
2028 200.1 4.8

Source: Market Research Future, 2023.

Key Market Drivers

Growth in Cosmetic Industry

PABA’s role as a UV filter, especially in sunscreens, bolsters demand. Rising awareness of skin protection and increased sunscreen consumption in regions such as Asia-Pacific and North America drive market expansion.

Pharmaceutical Applications

PABA is an intermediate in the synthesis of certain antibiotics (e.g., sulfonamides). Increased investment in antibiotic research and development supports demand.

Industrial and Food Grade Uses

PABA is used in the manufacturing of dyes and food preservatives, although these represent smaller segments.

Regional Market Trends

Region Market Share (2022) CAGR (2023-2028) Notes
Asia-Pacific 45% 5.2% Driven by cosmetic manufacturing and medicines
North America 25% 4.5% Established cosmetic industry, regulatory support
Europe 20% 4.6% Focus on pharmaceutical applications, regulations
Rest of World 10% 4.9% Emerging markets, growing industrial applications

Supply Chain and Production Dynamics

Raw Materials

Aminobenzoic acid is produced mainly via:

  • Chlorination of aniline followed by amination.
  • Hydrolysis of nitrobenzene derivatives.

Major producers include China, India, and the United States, collectively holding over 70% of global output.

Production Challenges

Environmental regulations impact manufacturing due to the use of hazardous reagents such as chlorinated compounds and nitrobenzene. Investment in cleaner, sustainable processes is increasing.

Pricing Trends

Average FOB China price was USD 8 per kg in 2022, with slight fluctuations driven by raw material costs and regional regulatory changes.

Competitive Landscape

Leading players:

  1. BASF SE – Focus on sustainable production methods.
  2. Shandong Liaocheng Ran Chemical Co. Ltd. – Cost-effective manufacturing.
  3. Tianjin Tina Chemical Co. Ltd. – Diversified product portfolio.

Market fragmentation persists, with several regional producers filling niche markets through competitive pricing and tailored quality standards.

Regulatory Environment and Investment Outlook

Regulatory standards

  • US FDA permits PABA in over-the-counter sunscreen formulations.
  • European Commission registers PABA as a UV filter with specific safety thresholds.

Investment trends

Biotechnological innovations aim to reduce environmental impacts and improve yield. Increased R&D spending by portfolio companies signals a positive long-term outlook.

Financial Trajectory

Revenue Projection

Companies producing PABA are expected to see stable revenue growth aligned with market CAGR of 4.8%. Margins are influenced by raw material costs, regulatory compliance, and production efficiencies.

Cost Factors

  • Raw material pricing volatility.
  • Environmental compliance expenses.
  • Innovation investments in greener synthesis pathways.

Profitability Outlook

Profit margins for leading producers range typically between 10-15%, with potential for expansion as sustainable manufacturing gains adoption.

Key Takeaways

  • The aminobenzoic acid market is growing modestly, driven by cosmetic and pharmaceutical applications.
  • Asia-Pacific dominates regional demand, bolstered by robust production and consumption.
  • Supply chain consolidation is limited, with regional players maintaining significance through cost advantages.
  • The environmental regulatory landscape influences production costs and technological innovation.
  • Investment in sustainable manufacturing and R&D remains critical for future growth.

5 FAQs

1. What are the primary applications of aminobenzoic acid?
PABA is used mainly in sunscreens as a UV filter, in antibiotics synthesis, and as an intermediate in dye production.

2. Which regions are the largest markets for PABA?
Asia-Pacific accounts for around 45% of demand, followed by North America and Europe.

3. How do environmental regulations affect manufacturing?
They increase compliance costs, promote cleaner production methods, and influence market entry for new manufacturers.

4. What is the outlook for prices of aminobenzoic acid?
Prices are expected to fluctuate around USD 8 per kg, influenced by raw material prices and regulatory changes.

5. Who are the dominant producers?
BASF, Shandong Liaocheng Ran Chemical, and Tianjin Tina Chemical are leading global suppliers.

References

  1. Market Research Future. (2023). Global Aminobenzoic Acid Market Analysis.
  2. U.S. Food and Drug Administration. (2022). Regulations on UV Filters.
  3. European Chemicals Agency. (2022). Regulatory Framework for UV Filters.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.